Drug discovery is slow, inefficient, and risky. It’s also costly—very costly. The median cost of developing a cancer drug, for example, is about (US)$680 million. Worldwide, the cost of developing a single drug exceeds (US)$2.5 billion.
When pharmaceutical companies invest millions in drug discovery, one thing’s certain: They want their products to retain quality, efficacy, and safety once they enter the marketplace. Stability testing ensures that a drug does so by determining both the shelf-life and the quality of a drug.